Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
56,000
Employees56,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
56,000
Employees56,000

DGX Key Statistics

Market cap
25.07B
Market cap25.07B
Price-Earnings ratio
23.47
Price-Earnings ratio23.47
Dividend yield
1.56%
Dividend yield1.56%
Average volume
1.33M
Average volume1.33M
High today
$210.36
High today$210.36
Low today
$201.99
Low today$201.99
Open price
$205.79
Open price$205.79
Volume
1.43M
Volume1.43M
52 Week high
$210.38
52 Week high$210.38
52 Week low
$157.20
52 Week low$157.20

Stock Snapshot

With a market cap of 25.07B, Quest Diagnostics(DGX) trades at $209.32. The stock has a price-to-earnings ratio of 23.47 and currently yields dividends of 1.6%.

During the trading session on 2026-02-12, Quest Diagnostics(DGX) shares reached a daily high of $210.36 and a low of $201.99. At a current price of $209.32, the stock is +3.6% higher than the low and still -0.5% under the high.

Trading activity shows a volume of 1.43M, compared to an average daily volume of 1.33M.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $210.38 and a low of $157.20.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $210.38 and a low of $157.20.

DGX News

TipRanks 21h
Quest Diagnostics price target raised to $210 from $190 at UBS

UBS raised the firm’s price target on Quest Diagnostics (DGX) to $210 from $190 and keeps a Neutral rating on the shares. Published first on TheFly – the ultim...

Nasdaq 23h
DGX Crosses Above Average Analyst Target

In recent trading, shares of Quest Diagnostics, Inc. (Symbol: DGX) have crossed above the average analyst 12-month target price of $188.71, changing hands for $...

DGX Crosses Above Average Analyst Target
Simply Wall St 1d
Quest Diagnostics 9% Net Margin Resurgence Challenges Long Term Earnings Decline Narrative

Advertisement Quest Diagnostics FY 2025 earnings in focus Quest Diagnostics (DGX) has put its FY 2025 numbers on the table with Q4 revenue of US$2.8 billion a...

Quest Diagnostics 9% Net Margin Resurgence Challenges Long Term Earnings Decline Narrative

Analyst ratings

50%

of 16 ratings
Buy
43.8%
Hold
50%
Sell
6.3%

More DGX News

TipRanks 1d
Quest Diagnostics Signals Growth Amid Margin Pressures

Quest Diagnostics ((DGX)) has held its Q4 earnings call. Read on for the main highlights of the call. Valentine's Day Sale - 70% Off Unlock hedge fund-level dat...

Benzinga 2d
Quest Diagnostics Stock Smashes 52-Week High On Strong Quarter, Dividend Hike

Quest Diagnostics Incorporated (NYSE:DGX) on Tuesday reported fourth-quarter adjusted earnings of $2.42 per share, beating the consensus of $2.36. The provider...

Quest Diagnostics Stock Smashes 52-Week High On Strong Quarter, Dividend Hike
The Motley Fool 2d
Quest Diagnostics Earnings Call Transcript

Image source: The Motley Fool. Tuesday, February 10, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chairman, Chief Executive Officer, and President — Jim Davis Execut...

Quest Diagnostics Earnings Call Transcript
TipRanks 2d
Quest Diagnostics Posts Strong 2025 Results, Boosts Shareholder Returns

Quest Diagnostics ( (DGX) ) has issued an announcement. On February 10, 2026, Quest Diagnostics reported that fourth-quarter 2025 revenue rose 7.1% year-on-yea...

Nasdaq 2d
Quest Diagnostics Guides FY26 Above Estimates; Boosts Dividend 7.5% - Update

(RTTNews) - While reporting financial results for the fourth quarter on Tuesday, diagnostic services firm Quest Diagnostics, Inc. (DGX) initiated its earnings,...

Quest Diagnostics Guides FY26 Above Estimates; Boosts Dividend 7.5% - Update
Nasdaq 2d
Quest Diagnostics Boosts Dividend 7.5%, Adds $1 Bln To Buyback Program

(RTTNews) - Quest Diagnostics Inc. (DGX) on Tuesday said its board has approved a 7.5% increase in the quarterly cash dividend to $0.86 per share from $0.80 per...

Quest Diagnostics Boosts Dividend 7.5%, Adds $1 Bln To Buyback Program
Nasdaq 2d
Quest Diagnostics Profit Climbs In Q4

(RTTNews) - Quest Diagnostics (DGX) announced earnings for its fourth quarter that Increases, from last year The company's earnings totaled $245 million, or $2...

Quest Diagnostics Profit Climbs In Q4

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.